Roger Nitsch

Roger Nitsch

Director/Board Member at LONZA GROUP AG

Net worth: 221 310 $ as of 2024-03-30

63 year
Health Technology
Commercial Services
Consumer Services

Profile

Roger Nitsch is the founder of Evotec International GmbH (founded in 1995), Neurimmune AG (founded in 2006), and NovaGo Therapeutics AG (founded in 2015).
At Evotec International GmbH, he held the title of Director from 1995 to 1998.
At Neurimmune AG, he holds the titles of President, Chief Executive Officer & Director.
At NovaGo Therapeutics AG, he holds the title of Director.
Currently, Dr. Nitsch holds multiple jobs, including Chairman at Neurimmune Holding AG, Independent Director at Lonza Group AG (since 2022), Director at INTEGRA Biosciences AG (since 2002), Director at AL-S Pharma AG, Professor at the Institute For Regenerative Medicine (since 1998), and Professor at the University of Zurich (since 2018).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-12-30 369 ( 0.00% ) 221 310 $ 2024-03-30

Roger Nitsch active positions

CompaniesPositionStart
LONZA GROUP AG Director/Board Member 2022-04-30
Director/Board Member -
Founder 2014-12-31
Neurimmune AG Founder 2005-12-31
Chairman -
Director/Board Member 2001-12-31
University of Zurich Corporate Officer/Principal 2017-12-31
Corporate Officer/Principal 1997-12-31
All active positions of Roger Nitsch

Former positions of Roger Nitsch

CompaniesPositionEnd
Founder 1997-12-31
See the detail of Roger Nitsch's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roger Nitsch's experience

Connections

59

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
LONZA GROUP AG

Health Technology

Private companies7

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Neurimmune AG

See company connections